Christine Nash

Christine Nash

Direttore/Membro del Consiglio presso RALLYBIO CORPORATION

Patrimonio netto: - $ in data 31/08/2026

53 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Ms. Christine A. Nash is an Independent Director at Rallybio Corp.
She is on the Board of Directors at Rallybio Corp.
Ms. Nash was previously employed as a Principal by Chatiemac Consulting LLC, a Chief Commercial Officer & Senior Vice President by Hyperion Therapeutics, Inc., a Marketing Director by CoTherix, Inc., a Principal by Eli Lilly & Co., a Product Manager by Genesoft Pharmaceuticals, Inc., a Principal by Imana, Inc., and a Principal by Oncology Therapeutics Network Corp.
She also served on the board at CM Group LLC.
She received her undergraduate degree from Stanford University and an MBA from Stanford University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
19/12/2025 0 ( -.--% ) - $ 31/08/2026

Posizioni attive di Christine Nash

SocietàPosizioneInizio
RALLYBIO CORPORATION Direttore/Membro del Consiglio 04/04/2022

Precedenti posizioni note di Christine Nash

SocietàPosizioneFine
Direttore/Membro del Consiglio 01/09/2022
HYPERION THERAPEUTICS INC Corporate Officer/Principal 01/05/2015
Vendite & Marketing 01/02/2007
Chatiemac Consulting LLC
Corporate Officer/Principal -
Imana, Inc.
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Christine Nash

Formazione di Christine Nash

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

62

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Distribution Services

Technology Services

Imana, Inc.

Health Technology

Chatiemac Consulting LLC

  1. Mercati
  2. Insiders
  3. Christine Nash